-
公开(公告)号:MX9803810A
公开(公告)日:1998-09-30
申请号:MX9803810
申请日:1998-05-13
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , HAJDUK PHILIP J
IPC: G01R33/465 , C12Q1/00 , G01N20060101 , G01N24/08 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/542 , G01N33/566 , G01N33/58 , G01N33/68
Abstract: La presente invencion proporciona un proceso para identificar compuestos que se fijan a una molécula objetivo específica. El proceso incluye los pasos de: a) generar un primer espectro de correlacion de resonancia magnética nuclear de 15N/1H bidimensional de una molécula objetivo etiquetada con 15N; b) exponer la molécula objetivo etiquetada a un compuesto químico o una mezcla de compuestos químicos; c) generar un segundo espectro de correlacion de resonancia magnética nuclear de 15N/1H bidimensional de la molécula objetivo etiquetada que se ha expuesto a un compuesto o una mezcla de compuestos en el paso (b); y d) comparar el primero y segundo espectros de correlacion de resonancia magnética nuclear de 15N/1H bidimensional para determinar las diferencias entre el primero y segundo espectros, las diferencias identificando la presencia de uno o más compuestos que son ligandos que se han fijado a la molécula objetivo.
-
公开(公告)号:MX9803805A
公开(公告)日:1998-09-30
申请号:MX9803805
申请日:1998-05-13
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , HAJDUK PHILIP J , OLEJNICZAK EDWARD T
IPC: G01R33/465 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/543 , G01N33/68 , G01N33/94 , G01R33/32 , G01R33/46 , G01N33/48 , G01N24/08
Abstract: La presente invencion proporciona un proceso para diseñar compuestos que se fijen a una molécula objetivo específica. El proceso incluye los pasos de a) identificar un primer ligando para la molécula objetivo, usando espectroscopía de correlacion de resonancia magnética nuclear de 15N/1H bidimensional; b) identificar un segundo ligando para la molécula objetivo usando espectroscopía de correlacion de resonancia magnética nuclear de 15N/1H bidimensional; c) formar un complejo ternario mediante la fijacion del primero y segundo ligandos a la molécula objetivo; d) determinar la estructura tridimensional del complejo y, de esta manera, la orientacion espacial del primero y segundo ligandos en la molécula objetivo; y e) enlazar el primero y segundo ligados para formar el fármaco, en donde se mantenga la orientacion espacial del paso d).
-
公开(公告)号:CA2653959A1
公开(公告)日:1997-05-22
申请号:CA2653959
申请日:1996-11-13
Applicant: ABBOTT LAB
Inventor: HAJDUK PHILIP J , OLEJNICZAK EDWARD T , FESIK STEPHEN W
Abstract: The present invention provides a process of designing compounds which bind t o a specific target molecule. The process includes the steps of a) identifying a first ligand to the target molecule using two-dimensional 15N/1H NMR correlation spectroscop y; b) identifying a second ligand to the target molecule using two-dimensional 15N/1H NMR correlation spectroscopy; c) forming a ternary complex by binding the first and second ligands to the target molecule; d) determining the three-dimensional structu re of the ternary complex and thus the spatial orientation of the first and second ligands on the target molecule; and e) linking the first and second ligands to form the dru g, wherein the spatial orientation of step (d) is maintained.
-
34.
公开(公告)号:CA2286795C
公开(公告)日:2010-06-29
申请号:CA2286795
申请日:1998-04-17
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN , HAJDUK PHILIP J , OLEJNICZAK EDWARD T
IPC: G01N24/08 , G01R33/32 , A61K45/00 , C07K14/705 , C12N9/00 , C12Q1/68 , C40B30/04 , C40B30/10 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/68 , G01R33/44 , G01R33/465
Abstract: The present invention provides a process for identifying compounds which bind to a specific target molecule. The process comprises the steps of: a) generating a first T2- or diffusion-filtered proton spectrum of one or a mixture of chemical compounds; b) exposing one or a mixture of chemical compounds to the target molecule; c) generating a second T2- or diffusion-filtered proton spectrum of one or a mixture of chemical compounds that has been exposed to the target molecule in step (b); and d) comparing said first and second T2- or diffusion-filtered proton spectra to determine differences between said first and said second spectra, the differences identifying the presence of one or more compounds that are ligands which have bound to the target molecule.
-
35.
公开(公告)号:ES2143793T5
公开(公告)日:2008-03-01
申请号:ES96940448
申请日:1996-11-13
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , HAJDUK PHILIP J
IPC: G01N33/50 , G01R33/465 , C12Q1/00 , G01N20060101 , G01N24/08 , G01N33/15 , G01N33/53 , G01N33/542 , G01N33/566 , G01N33/58 , G01N33/68
Abstract: LA PRESENTE INVENCION PROPORCIONA UN PROCESO PARA IDENTIFICAR COMPUESTOS QUE SE UNEN A UNA MOLECULA DIANA ESPECIFICA. EL PROCESO INCLUYE LOS PASOS DE: A) GENERAR UN PRIMER ESPECTRO DE CORRELACION BIDIMENSIONAL 15 N/ 1 H NMR DE UNA MOLECULA DIANA ETIQUETADA 15 N; B) EXPONER LA MOLECULA DIANA E TIQUETADA A UN COMPUESTO QUIMICO O A UNA MEZCLA DE COMPUESTOS QUIMICOS; C) GENERAR UN SEGUNDO ESPECTRO DE CORRELACION BIDIMENSIONAL 15 N/ 1 H NMR DE LA MOLECULA DIANA ETIQUETADA QUE SE HA EXPUESTO A UN COMPUESTO O A UNA MEZCLA DE COMPUESTOS EN EL PASO (B); Y D) COMPARAR EL PRIMER Y SEGUNDO ESPECTRO DE CORRELACION BIDIMENSIONAL 15 N/ 1 H NMR PARA DETERMINAR LAS DIFERENCIAS ENTRE EL PRIMER Y SEGUNDO ESPECTRO MENCIONADOS, DIFERENCIAS QUE IDENTIFICAN LA PRESENCIA DE UNO O MAS COMPUESTOS QUE SON LIGANDOS QUE SE HAN UNIDO A LA MOLECULA DIANA.
-
公开(公告)号:DK0866967T4
公开(公告)日:2007-12-10
申请号:DK96940448
申请日:1996-11-13
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , HAJDUK PHILIP J
IPC: G01N33/50 , G01R33/465 , C12Q1/00 , G01N20060101 , G01N24/08 , G01N33/15 , G01N33/53 , G01N33/542 , G01N33/566 , G01N33/58 , G01N33/68
Abstract: A method for designing and forming a ligand which binds to a specific target molecule comprises the steps of: (a) identifying a first ligand moiety that binds to the target molecule using two-dimensional N/ H NMR correlation spectroscopy; (b) identifying subsequent ligand moieties that bind to the target molecule using two-dimensional N/ H NMR correlation spectroscopy; (c) forming a complex of the first and subsequent ligand moieties to the target molecule; (d) determining the three-dimensional structure of the complex and, thus, the spatial orientation of the first and subsequent ligand moieties on the target molecule; and (e) linking the first and subsequent ligand moieties to form a new ligand to maintain the spatial orientation of the ligand moieties.
-
公开(公告)号:BR0110101A
公开(公告)日:2005-06-07
申请号:BR0110101
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL D
IPC: A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107 , C07C311/00
-
公开(公告)号:BG64326B1
公开(公告)日:2004-09-30
申请号:BG10385699
申请日:1999-11-04
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , HAJDUK PHILIP J , OLEJNICZAK EDWARD T
IPC: G01R33/32 , A61K45/00 , C07K14/705 , C12N9/00 , C12Q1/68 , G01N24/08 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/68 , G01R33/44
Abstract: The invention relates to a method for the identification of compounds which are bound to a specific molecule target. It includes the following stages: (a) production of first T2- or diffusion filtered proton spectrum of one or of a mixture of chemical compounds; (b) subjection of one or of a mixture of chemical compounds to the effect of a target molecule; (c) production of a second T2- or diffusion filtered proton spectrum of one or of a mixture of chemical compounds which are subjected to the effect of a molecule target in stage (b), and (d) comparison of the first and the second T2- or the diffusion filtered proton spetra in order to determine the differences between the first and the second spectrum, the differences identifying the presence of one or more compounds which are ligands bound to the target molecule. 26 claims, 6 figures
-
公开(公告)号:DE69631842D1
公开(公告)日:2004-04-15
申请号:DE69631842
申请日:1996-11-13
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , HAJDUK PHILIP J
IPC: G01R33/465 , C12Q1/00 , G01N20060101 , G01N24/08 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/542 , G01N33/566 , G01N33/58 , G01N33/68
Abstract: A method for designing and forming a ligand which binds to a specific target molecule comprises the steps of: (a) identifying a first ligand moiety that binds to the target molecule using two-dimensional N/ H NMR correlation spectroscopy; (b) identifying subsequent ligand moieties that bind to the target molecule using two-dimensional N/ H NMR correlation spectroscopy; (c) forming a complex of the first and subsequent ligand moieties to the target molecule; (d) determining the three-dimensional structure of the complex and, thus, the spatial orientation of the first and subsequent ligand moieties on the target molecule; and (e) linking the first and subsequent ligand moieties to form a new ligand to maintain the spatial orientation of the ligand moieties.
-
公开(公告)号:PE20020504A1
公开(公告)日:2002-06-20
申请号:PE2001000940
申请日:2001-09-19
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , WANG XILU , BAUMEISTER STEVEN A , DING HONG , FESIK STEPHEN W , KUNZER AARON R , PETROS ANDREW M , WENDT MICHAEL D , THOMAS SHEELA A , SHEN WANG , ROSEMBERG SAUL H , NETTERSHEIM DAVID G , HAJDUK PHILIP J , DINGES JURGEN , DICKMAN DANIEL A , AUGERI DAVID J , BRUNCKO MILAN
IPC: C07C311/00 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/12 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/96 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/61 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D235/08 , C07D235/26 , C07D241/16 , C07D249/04 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D401/06 , C07D401/12 , C07D405/04 , C07D417/12 , C07D451/02
Abstract: SE REFIERE A N-ACILSULFONAMIDAS DE FORMULA I DONDE A ES FENILO, ANILLO CARBOCICLICO AROMATICO DE 5-6 MIEMBROS; R1 ES ALQUILO, HALOALQUILO, NITRO, NR5R6; R2 Y R3 SON H, ALQUENILO, ALCOXI, ALQUILO, ALQUILSULFANILO, ALQUINILO, ARILO, ARILALCOXI, ENTRE OTROS; R4 ES ARILO, ARILALQUENILO, ARILALCOXI, ARILOXI, ARILOXIALCOXI, ENTRE OTROS; R5 Y R6 SON HIDROGENO, ALQUENILO, ALCOXIALQUILO, ENTRE OTROS; R5 Y R6 JUNTO A N FORMAN UN IMIDAZOLILO, MORFOLINILO, PIPERAZINILO, PIPERIDINILO, ENTRE OTROS; R15 ES H, ALQUILO, HALO. SON COMPUESTOS PREFERIDOS 4-((2,2-DIMETILCICLOPENTIL)AMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, 4-(CICLOHEXILAMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS MENCIONADOS SON PROMOTORES DE LA APOPTOSIS Y SON UTILES PARA EL TRATAMIENTO DEL CANCER
-
-
-
-
-
-
-
-
-